BANK VONTOBEL/PUT/EDWARDS LIFESCIENCES/68/0.1/20.12.24 | Market Closed - Börse Stuttgart 12:13:24 27/06/2024 pm IST | ||
| 0.076 EUR | -2.56% |
|
| Current month | -31.53% | ||
| 1 month | -29.63% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 27/24/27 | 0.076 | -2.56% |
| 26/24/26 | 0.078 | +2.63% |
| 25/24/25 | 0.076 | -14.61% |
| 24/24/24 | 0.089 | -16.82% |
| 21/24/21 | 0.107 | -6.96% |
Delayed Quote Börse Stuttgart
Last update June 27, 2024 at 12:13 pm IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VD4BB3 |
| ISIN | DE000VD4BB31 |
| Date issued | 16/04/2024 |
| Strike | 68 $ |
| Maturity | 20/12/2024 (176 Days) |
| Parity | 10 : 1 |
| Emission price | 0.17 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.228 € |
|---|---|
| Lowest since issue | 0.076 € |
| Delta | -0.03x |
| Omega | 5.166 |
| Premium | 51.73x |
| Gearing | 194.37x |
| Moneyness | 0.4878 |
| Difference Strike | -25.34 $ |
| Difference Strike % | -37.26% |
| Spread | 0.01 € |
| Spread % | 13.89% |
| Theoretical value | 0.0670 |
| Implied Volatility | 62.39 % |
| Total Loss Probability | 93.33 % |
| Intrinsic value | 0.000000 |
| Present value | 0.0670 |
| Break even | 67.28 € |
| Theta | -0.01x |
| Vega | 0.01x |
| Rho | -0x |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
93.34
USD
Average target price
96.05
USD
Spread / Average Target
+2.91%
- Stock Market
- Warrants
- Warrant
